Simplified hierarchical linear models for the evaluation of surrogate endpoints
From MaRDI portal
Publication:4432903
DOI10.1080/0094965031000062177zbMath1184.62120OpenAlexW2097444513WikidataQ59901736 ScholiaQ59901736MaRDI QIDQ4432903
Geert Molenberghs, Fabián S. Tibaldi, Russ Wolfinger, Marc Buyse, Tomasz Burzykowski, Theo Stijnen, José Cortiñas Abrahantes, Max Parmar, Didier Renard
Publication date: 29 October 2003
Published in: Journal of Statistical Computation and Simulation (Search for Journal in Brave)
Full work available at URL: http://hdl.handle.net/1942/421
Related Items (11)
Center-within-trial versus trial-level evaluation of surrogate endpoints ⋮ Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach ⋮ On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints ⋮ Simplified modeling strategies for surrogate validation with multivariate failure-time data ⋮ Choice of units of analysis and modeling strategies in multilevel hierarchical models ⋮ The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials ⋮ Using earlier measures in a longitudinal sequence as a potential surrogate for a later one ⋮ Statistical evaluation of surrogate endpoints with examples from cancer clinical trials ⋮ An information-theoretic approach to surrogate-marker evaluation with failure time endpoints ⋮ Unbalanced cluster sizes and rates of convergence in mixed-effects models for clustered data ⋮ Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS
This page was built for publication: Simplified hierarchical linear models for the evaluation of surrogate endpoints